The Department of Health and Human Services Feb. 5 in a court filing said it would scrap its current 340B Rebate Model Pilot ...
Many Americans may be unaware that the services they rely on every day through their local hospital are supported by a program called the 340B Drug Pricing Program.
Henry Ford Health, one of Michigan’s largest 340B health systems, spent $90 million on a naming and branding partnership with ...
The US Department of Health and Human Services and hospitals groups are scrapping a legal fight over a drug rebate pilot after federal officials said they would take another look at the program.
The view inside a CVS pharmacy. (Photo by Lynne Terry/Oregon Capital Chronicle) In May 2025, Gov. Jared Polis signed Senate Bill 71 into law, dramatically expanding Colorado’s participation in the ...
Health Affairs' Rob Lott interviews Sayeh Nikpay of the University of Minnesota about her recent paper exploring how The Medicaid Drug Rebate Program and the 340B Program interact in ways that can ...
The cost of prescription drugs is certain to be a hot-button issue in the coming Illinois legislative session with two separate measures making for curious bedfellows in Springfield.
A federal judge granted a temporary restraining order to block a pilot program aimed at keeping better tabs on the federal 340B hospitals use to receive drug discounts. The pilot was scheduled to ...
A federal judge has issued a preliminary injunction halting the Department of Health and Human Services’ (HHS) 340B Rebate Model Pilot Program, which was scheduled to take effect on January 1, 2026.
Pharmacy leaders should watch Medicare MFP as it changes Part D drug pricing and introduces new reconciliation challenges for ...
Court blocks Trump administration's drug rebate program for safety-net hospitals Judges cite lack of impact consideration on hospitals Inflation Reduction Act allows Medicare drug price negotiations ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...